Avastin filed for lung cancer in Japan
November 27th, 2008
Chugai (Roche) has filed a submission in Japan for the approval of Avastin (bevacizumab) for the additional indication of non-small cell lung cancer.
ALMOST 80% OF NEW LC DIAGNOSES
ARE IN NEVERSMOKERS OR
PEOPLE WHO QUIT LONG AGO